ifosfamide has been researched along with Angiogenesis, Pathologic in 4 studies
Excerpt | Relevance | Reference |
---|---|---|
"Soft tissue sarcomas are a heterogeneous group of connective tissue tumors, with more than 50 different subtypes." | 2.44 | Chemotherapeutic management of soft tissue sarcoma. ( Thornton, K, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wakamatsu, T | 1 |
Naka, N | 1 |
Sasagawa, S | 1 |
Tanaka, T | 1 |
Takenaka, S | 1 |
Araki, N | 1 |
Ueda, T | 1 |
Nishizawa, Y | 1 |
Yoshikawa, H | 1 |
Itoh, K | 1 |
Thornton, K | 1 |
Schmitt, O | 1 |
Schubert, C | 1 |
Feyerabend, T | 1 |
Hellwig-Bürgel, T | 1 |
Weiss, C | 1 |
Kühnel, W | 1 |
Lichtenberg, J | 1 |
Larsson, LI | 1 |
1 review available for ifosfamide and Angiogenesis, Pathologic
Article | Year |
---|---|
Chemotherapeutic management of soft tissue sarcoma.
Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Chemotherap | 2008 |
3 other studies available for ifosfamide and Angiogenesis, Pathologic
Article | Year |
---|---|
Deflection of vascular endothelial growth factor action by SS18-SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line, Tumor; | 2014 |
Preferential topography of proteins regulating vascularization and apoptosis in a MX1 xenotransplant after treatment with hypoxia, hyperthermia, ifosfamide, and irradiation.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Breast Neoplasms; Cell Adhesion Molecules; Co | 2002 |
A mouse model for the study of factors affecting angiogenesis.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Disease Models, Anima | 2002 |